Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase NA 1Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 5Lymphoid 3Gastrointestinal 3Plasma cell 2NET 2Endocrine 2Breast 2Other hematologic neoplasm 1Head & Neck 1Gynecologic 1CNS 1

Conditions

Uterine Cervical Neoplasms 1Hypoxia 1

Interventions

Paclitaxel 233Carboplatin 217Bevacizumab 139Cisplatin 136pembrolizumab 89Gemcitabine 69olaparib 54Docetaxel 47Topotecan 44Radiotherapy 43liposomal doxorubicin 41Taxes 41niraparib 38Cyclophosphamide 36Doxorubicin 30Drug Therapy 29Letrozole 28Nivolumab 27Magnetic Resonance Spectroscopy 25Immunoglobulin G 25Disulfides 24Oxaliplatin 23Albumin-Bound Paclitaxel 23durvalumab 22apatinib 21Etoposide 21Brachytherapy 21lenvatinib 20camrelizumab 20Specimen Handling 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Positron Emission Tomography Computed Tomography × Gynecologic × Clear all
NCT06353061 2025-01-14

Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer

Peking Union Medical College Hospital

Phase 2 Unknown
51 enrolled
Gynecologic

Hypoxia, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡